Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chava Perry

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
The Israel Medical Association Journal : IMAJ|February 12, 2014
JAK2 mutation: an aid in the diagnosis of occult myeloproliferative neoplasms in patients with major intraabdominal vein thrombosis and normal blood countsNadav Sarid, Rinat Eshel, Einam Rahamim, et al.
Leukemia Research|August 14, 2013
Absolute monocyte count trichotomizes chronic lymphocytic leukemia into high risk patients with immune dysregulation, disease progression and poor survivalYair Herishanu, Sigi Kay, Nadav Sarid, et al.
Frontiers in Oncology|May 31, 2021
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL CellsYamit Shorer Arbel, Ben-Zion Katz, Ronen Gabizon, et al.
Bone Marrow Transplantation|November 24, 2020
Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease-a single center case seriesEfrat Luttwak, David Hagin, Chava Perry, et al.
Annals of Hematology|June 13, 2025
Efficacy and safety of Glofitamab in patients with R/R DLBCL in real life setting- a retrospective studyRonit Gurion, Dmitri Guz, Meirav Kedmi, et al.
Annals of Hematology|May 20, 2019
Interim PET-CT-guided therapy in elderly patients with Hodgkin lymphoma-a retrospective national multi-center studyO S Bentur, E J Dann, E Paran, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2021
[<sup>18</sup>F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studiesDan Cohen, Efrat Luttwak, Ofrat Beyar-Katz, et al.
Blood|April 16, 2021
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemiaYair Herishanu, Irit Avivi, Anat Aharon, et al.
Hematological Oncology|November 2, 2019
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational studyShai Shimony, Netanel Horowitz, Elena Ribakovsky, et al.
Leukemia & Lymphoma|May 7, 2015
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center studyAnat Gafter-Gvili, Elena Ribakovsky, Nadav Mizrahi, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
The Israel Medical Association Journal : IMAJ|February 12, 2014
JAK2 mutation: an aid in the diagnosis of occult myeloproliferative neoplasms in patients with major intraabdominal vein thrombosis and normal blood countsNadav Sarid, Rinat Eshel, Einam Rahamim, et al.
Leukemia Research|August 14, 2013
Absolute monocyte count trichotomizes chronic lymphocytic leukemia into high risk patients with immune dysregulation, disease progression and poor survivalYair Herishanu, Sigi Kay, Nadav Sarid, et al.
Frontiers in Oncology|May 31, 2021
Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL CellsYamit Shorer Arbel, Ben-Zion Katz, Ronen Gabizon, et al.
Bone Marrow Transplantation|November 24, 2020
Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease-a single center case seriesEfrat Luttwak, David Hagin, Chava Perry, et al.
Annals of Hematology|June 13, 2025
Efficacy and safety of Glofitamab in patients with R/R DLBCL in real life setting- a retrospective studyRonit Gurion, Dmitri Guz, Meirav Kedmi, et al.
Annals of Hematology|May 20, 2019
Interim PET-CT-guided therapy in elderly patients with Hodgkin lymphoma-a retrospective national multi-center studyO S Bentur, E J Dann, E Paran, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2021
[<sup>18</sup>F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studiesDan Cohen, Efrat Luttwak, Ofrat Beyar-Katz, et al.
Blood|April 16, 2021
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemiaYair Herishanu, Irit Avivi, Anat Aharon, et al.
Hematological Oncology|November 2, 2019
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational studyShai Shimony, Netanel Horowitz, Elena Ribakovsky, et al.
Leukemia & Lymphoma|May 7, 2015
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center studyAnat Gafter-Gvili, Elena Ribakovsky, Nadav Mizrahi, et al.
Pageof 8